IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
Facebook Twitter LinkedIn Potomac, MD, March 20, 2024 – IGC Pharma, Inc. ( IGC Pharma , IGC , or the Company ) (NYSE American: IGC) today announced that Ram Mukunda, CEO, and Claudia Grimaldi, Vice President, will participate in a fire chat at the BENZINGA VIRTUAL HEALTHCARE SUMMIT 2024 (https://www.benzinga.com/events/virtual-healthcare-summit-2024/). Benzinga virtual healthcare summit 2024 […]
IGC Pharma Reports Third Quarter Fiscal 2024 Results
Facebook Twitter LinkedIn POTOMAC, MD. February 16, 2024 / IGC Pharma, Inc. ( IGC or the Company ) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2024 ended December 31, 2023 (Q3 FY 2024). Q3 FY2024 Highlights On October 18, 2023, the European Patent Office ( EPO ) issued […]
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
– IGC Pharma to Discuss AI Partnership and Initiatives at Biotech Showcase 2024 – Facebook Twitter LinkedIn POTOMAC, MD. December 13, 2023 / IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced that the Company’s management team will participate in Biotech Showcase and BIO Partnering @ JPM, held in-person and scheduled alongside […]
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
– IGC Pharma to Discuss AI Partnership and Initiatives at Biotech Showcase 2024 – Facebook Twitter LinkedIn POTOMAC, MD. December 6, 2023 / IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced an Artificial Intelligence (AI) collaboration with Los Andes University’s Center for Research and Training in Artificial Intelligence ( CINFONIA ). […]